United States International Trade Commision Rulings And Harmonized Tariff Schedule
faqs.org  Rulings By Number  Rulings By Category  Tariff Numbers
faqs.org > Rulings and Tariffs Home > Rulings By Number > 2008 NY Rulings > NY N026190 - NY N026273 > NY N026223

Previous Ruling Next Ruling
NY N026223

April 17, 2008



TARIFF NO.: 3006.60.0000

Mr. Colm Moynihan
NorthStar Healthcare Limited
3300 Cork Airport Business Park
Cork, Ireland

RE: The tariff classification of Norgestimate (CAS-35189-28-7) imported in dosage/tablet form, from India. Correction to Ruling Number N025975

Dear Mr. Moynihan:

This replaces Ruling Number N025975, dated April 16, 2008, which contained a clerical error with regard to the tariff classification of Norgestimate. A complete corrected ruling follows.

In your letter dated April 10, 2008, you requested a tariff classification ruling.

The subject product, Norgestimate is a medicinal preparation containing Norgestimate, a synthetic progestin, as the active ingredient. It is indicated for use in conjunction with estrogen for hormone replacement therapy in postmenopausal women, and for contraception.

The applicable subheading for the Norgestimate in dosage/tablet form will be 3006.60.0000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Pharmaceutical products specified in note 4 to this chapter: Chemical contraceptive preparations based on hormones, on other products of heading 2937 or on spermicides.” The rate of duty will be free.

Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/.

This product may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov.

This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177).

A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at 646-733-3033.


Robert B. Swierupski

Previous Ruling Next Ruling

See also: